UK Health Minister Matt Hancock warned that the country was in a “dangerous time” with more than 17,540 new cases a day on Thursday, while Britain’s parliament was due to vote Tuesday on imposing the a closing time at 10pm for English pubs. bars and restaurants. Staff at branches of some of Britain’s largest banks say rules requiring them to put phones in lockers while at work put them at undue risk of COVID-19 from their colleagues and customers as they cannot use the country tracking app.
In Russia, authorities recommended that people stay home this weekend, as the number of new cases soared to almost the highest level since the pandemic began. Meanwhile, the Czech government will tighten measures against the coronavirus starting next week with new restrictions on sports and cultural venues and restaurants as the country struggles with a wave of new cases.
Sufficient doses of a coronavirus vaccine could be made from March to April next year for every American who wants one, said US Secretary of Health and Human Services Alex Azar. The Speaker of the US House of Representatives, Nancy Pelosi, said that legislation to help airlines survive the pandemic was a matter of national security and could only be passed in Congress with guarantees that lawmakers will work. into a more comprehensive aid bill.
Malaysia has reported 375 new cases, the second consecutive day of declining infections as the Southeast Asian country moved to impose targeted closures to stem a further surge in infections.
The world’s largest annual religious gathering is in full swing and poses formidable health hazards for Iraqi authorities already battling a surge in infections. Jordan will enter a 48-hour national lockdown on Friday for the first time in months, as health officials fear a major spike in infections could threaten its extended health system.
The European Union has signed an agreement with Johnson & Johnson to supply up to 400 million doses of its possible Covid-19 vaccine. Eli Lilly and company reached an agreement to supply their experimental coronavirus drugs to low- and middle-income countries. He also said fewer deaths were reported among Covid patients taking a combination of their rheumatoid arthritis drug and Gilead Sciences’ remdesivir in a clinical trial, compared to remdesivir alone.
.
